SGMO - Sangamo Therapeutics Inc. (SGMO) CEO Sandy Macrae on Q4 2021 Results - Earnings Call Transcript
Sangamo Therapeutics, Inc. (SGMO) Q4 2021 Earnings Conference Call February 24, 2022 04:30 PM ET Company Participants Aron Feingold - Head of Corporate Communications Sandy Macrae - CEO Mark McClung - COO Prathyusha Duraibabu - CFO Jason Fontenot - Chief Scientific Officer Rob Schott - Head of Development Bettina Cockroft - Chief Medical Officer Conference Call Participants Nicole Germino - Truist Securities Yanan Zhu - Wells Fargo Maury Raycroft - Jefferies Luca Issi - RBC Capital Aspen Mori - Bank of America Ritu Baral - Cowen Gena Wang - Barclays Patrick Trucchio - HC Wainwright Presentation Operator Good day and thank you for standing by. Welcome to the Sangamo Therapeutics Fourth Quarter and Full Year 2021 Conference Call. At this time all participants are in listen only mode. After the speaker’s presentation there will be a question and answer session. [Operator Instructions] I’d now like to hand the conference over
For further details see:
Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q4 2021 Results - Earnings Call Transcript